article thumbnail

The Top Medical Cannabis Research of 2017

MGC Pharma

The Top Medical Cannabis Research of 2017 A word from Ron Lipsky, Manager of Business Development and International Relations at MGC Pharmaceuticals MGC Pharma is still riding off the success of 2017 as we progress into 2018, with many exciting developments on the horizon.

article thumbnail

Clinical Trial: Cannabinoid Administration Via a Metered-Dose Inhaler Is Safe and Effective for Chronic Pain Patients

NORML

Chronic pain is the most commonly reported qualifying condition among medical cannabis patients enrolled in state-specific access programs.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Pennsylvania: Marijuana possession arrests decline statewide

NORML

Pennsylvania began offering registration for the medical cannabis program in 2017. Those who face arrest or even summary offenses for possession are often made to undergo questionable and expensive drug treatment programs to avoid further prosecution. Most recently, in January, Norristown joined the list.

Marijuana 299
article thumbnail

Patients Frequently Substituting Cannabis For Anti-Anxiety Drugs

NORML

According to data compiled by the US Centers for Disease Control, the drug was attributed to over 11,500 overdose deaths in 2017. In the first study , Canadian researchers assessed the relationship between cannabis and benzodiazepines in a cohort of 146 patients enrolled in the nation’s medical marijuana access program.

Patients 237
article thumbnail

Studies: Medical Cannabis Enrollees Typically Reduce Their Use of Opioids

NORML

Patients diagnosed with chronic pain and other debilitating conditions typically reduce, or in some cases, eliminate their use of opioids following their enrollment in state-sanctioned medical cannabis access programs. Several peer-reviewed studies now document this trend. These conclusions are hardly unique. percent versus 44.8

article thumbnail

Study: Marijuana Provided For FDA-Approved Clinical Research Genetically Similar to Hemp

NORML

Authors reported that samples available via the U-Miss program shared genetics typically associated with industrial hemp, not commercially available cannabis. ” A separate study published in 2017 reported that U-Miss samples contain far lower levels of both THC and CBD than do commercially available cannabis.

Hemp 197
article thumbnail

Cannabichromene, a Minor Cannabinoid with Major Upside

Project CBD

These cells undergo a maturation process, known as differentiation , which is an important stage for young cells located in the spinal cord, brainstem, and brain regions programmed for muscle control. Young stem cells evolve into new neurons, but they can also form cells that comprise the protective sheath surrounding nerves. Life (Basel).